RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BARD1 Life Sciences Stock

BARD1 Life Sciences Debt 2024

BARD1 Life Sciences Debt

-3.73 AUD

Ticker

BD1.AX

ISIN

AU000000BD12

WKN

A2AL50

In 2024, BARD1 Life Sciences's total debt was -3.73 AUD, a 0% change from the 0 AUD total debt recorded in the previous year.

BARD1 Life Sciences Aktienanalyse

What does BARD1 Life Sciences do?

BARD1 Life Sciences Ltd. is an Australian biotechnology company specializing in the development of diagnostics and therapeutics for cancer. The company was founded in 1999 and is headquartered in Sydney. BARD1 Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding BARD1 Life Sciences's Debt Structure

BARD1 Life Sciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing BARD1 Life Sciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to BARD1 Life Sciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in BARD1 Life Sciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about BARD1 Life Sciences stock

What is the debt of BARD1 Life Sciences this year?

BARD1 Life Sciences has a debt level of -3.73 AUD this year.

What was the debt of BARD1 Life Sciences compared to the previous year?

The debt of BARD1 Life Sciences has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in BARD1 Life Sciences?

High debt can pose a risk for investors of BARD1 Life Sciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of BARD1 Life Sciences?

Low debt means that BARD1 Life Sciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from BARD1 Life Sciences affect the company?

An increase in debt of BARD1 Life Sciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of BARD1 Life Sciences affect the company?

A reduction in debt of BARD1 Life Sciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of BARD1 Life Sciences?

Some factors that can influence the debt of BARD1 Life Sciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of BARD1 Life Sciences so important for investors?

The debts of BARD1 Life Sciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can BARD1 Life Sciences take to change the debt?

To change the debt, BARD1 Life Sciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does BARD1 Life Sciences pay?

Over the past 12 months, BARD1 Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BARD1 Life Sciences is expected to pay a dividend of 0 AUD.

What is the dividend yield of BARD1 Life Sciences?

The current dividend yield of BARD1 Life Sciences is .

When does BARD1 Life Sciences pay dividends?

BARD1 Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BARD1 Life Sciences?

BARD1 Life Sciences paid dividends every year for the past 0 years.

What is the dividend of BARD1 Life Sciences?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BARD1 Life Sciences located?

BARD1 Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von BARD1 Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BARD1 Life Sciences from 11/3/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/3/2024.

When did BARD1 Life Sciences pay the last dividend?

The last dividend was paid out on 11/3/2024.

What was the dividend of BARD1 Life Sciences in the year 2023?

In the year 2023, BARD1 Life Sciences distributed 0 AUD as dividends.

In which currency does BARD1 Life Sciences pay out the dividend?

The dividends of BARD1 Life Sciences are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BARD1 Life Sciences

Our stock analysis for BARD1 Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BARD1 Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.